ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Northwell Health Pediatric Rheumatologist Recognized for Lifetime Achievement by the American College of Rheumatology

Barbara Anne Eberhard, MD, was named a master recipient of the award for her work and research in pediatric rheumatology.

For her dedication to research and leadership in rheumatology, Northwell Health’s Cohen Children’s Medical Center (CCMC) pediatric rheumatologist and Feinstein Institutes for Medical Research scientist Barbara Anne Eberhard, MD, has been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP). Dr. Eberhard was recognized, and named an “ACR Master,” during the ACR Convergence 2023 annual conference which is being held November 10-15 in San Diego, California.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231114668794/en/

Dr. Barbara Anne Eberhard was recognized for lifetime achievement by the American College of Rheumatology. (Credit: Feinstein Institutes)

Dr. Barbara Anne Eberhard was recognized for lifetime achievement by the American College of Rheumatology. (Credit: Feinstein Institutes)

The ACR Master recognition is awarded to physician-researchers who have made significant contributions to the field of rheumatology. Dr. Eberhard spent her two-decade-long career working clinically and as a teacher in pediatric rheumatology in the Department of Pediatrics at CCMC, while also taking on research roles at CCMC and at the Feinstein Institutes. Her focus is on the care of children living with rheumatologic conditions including arthritis, vasculitis, dermatomyositis and systemic lupus erythematosus.

“Children who are living with rheumatologic conditions need special care and people to advocate for research into new therapies that could lead them to live happier, healthier lives,” said Dr. Eberhard. “I am honored to be recognized by the ACR and hope to inspire others to continue the care and advance clinical trials and studies that may benefit our patients.”

Dr. Eberhard also leads the Pediatric Lupus Clinic at Northwell Health, caring for more than 200 patients with pediatric lupus. She was previously past chair of the lupus subcommittee in the Child, Arthritis and Rheumatology Research Alliance (CARRA) from 2008 through 2015. In that role, she helped establish one of the largest clinical databases of pediatric lupus in the world, which now consists of more than 900 patients. Through CARRA, Dr. Eberhard is active in defining consensus treatment guidelines for the use of biologics in other autoimmune diseases and has gathered data demonstrating improved patient outcomes. Her research has led to the publication of 70 papers and over 50 published abstracts. She has been a mentor to more than 20 clinical research fellows and junior faculty, and is a founding member of the ACR/CARRA Mentoring Interest Group (AMIGO) that matches young physician-researchers with mentors from external institutions based on their research and clinical interests.

“Dr. Eberhard is a leader in rheumatology clinical care and research,” said Charles Schleien, MD, MBA, senior vice president and chair of pediatric services at Northwell Health, and the Philip Lanzkowsky Chair and Professor of Pediatrics at the Zucker School of Medicine at Hofstra/Northwell. “This recognition will advance future research and promote collaboration among her peers and colleagues even more, which will in turn benefit patients, which is what this is all about.”

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.